cholinoceptor antagonists Flashcards
agonists vs antagonists
both have affinity, but only agonists have efficacy
where are nicotinic receptors- thus what are nicotinic receptor antagonists called
all ganglia of ANS, including adrenal gland (acts like a ganglion)
ganglion blocking drugs- both SNS and PNS
hexamethonium and trimetaphan
these are nicotinic receptor antagonists- these drugs either block ion channel or block receptor- trimetaphan better at blocking receptor
use-dependent block + comparison to competitive antagonist
relates to drugs blocking the ion channel- the more open the channels are, the more effective the antagonist is
unlike competitive antagonist (where the more agonist present, the less effective the drug), the more agonist present, the MORE effective the drug, as channel needs to be open for agonist to work
feature of ion channel block
it is INCOMPLETE, sodium/potassium can still get through, just not very effectively
do nicotinic receptor antagonist have affinity
yes if blocking receptor, no if blocking ion channel
overall effect of nicotinic receptor antagonists
they block whole ANS ie both SNS and PNS, but effect it seems to have depends on which system is dominant a t the time, so if SNS dominant, will seem to have anti-SNS effect
effects at REST after treatment of drug
anything that involves SNS, as at rest PNS is dominant (not blood vessels as only SNS effects that)
increased HR and bronchodilation
effects of hexamethonium on BP
lowers BP- it cause dilation of BLOOD VESSELS, it stops production of renin from KIDNEY (less aldosterone+ ANG2), and although it increases HR in HEART, overall effect is lower BP
side effects of hexamethonium
dilates pupil
saliva produces thick rather than watery secretion (thick due to SNS)
sweating goes down (only SNS has effect)
issues with gut motility and bladder
hexamethonium vs trimetaphan uses
hexa used as anti-hypertensive, although not much anymore due to side effects
trimetaphan used for hypotension during surgery (as short acting)
other nicotinic receptor antagonist+ effect
alpha-bungarotoxin (venom) is most powerful antagonist as permanently binds to receptor
main issue is somatic nervous system- paralyses you
take home message for nicotinic receptor antagonists- thus difference for muscarinic receptor antagonists
too messy- have too many unwanted side effects as effect all parts of ANS
muscarinic less messy, as these receptors only found in PNS and sweat gland nerves
main muscarinic receptor antagonists and effects of CNS+ possible reasons
atropine and hyoscine, both of which are very similar in structure, yet effect CNS differently
atropine has little effect with therapeutic dose, hyoscine causes sedation
atropin causes agitation at toxic dose, hyoscine causes CNS depression
may be because hyoscine more M1 selective (heavily targets one receptor), or hyoscine goes deeper into CNS
muscarinic receptor antagonist for eye
tropicamide allows examination of retina- because PNS causes pupil constriction (smaller pupil), so harder to examine back of eye- tropicamide prevents this
use as an anaesthetic premedication
PNS constricts BRONCHIOLES- by dilating it, anaesthetic can be better inhaled
PNS increases saliva- problem with anaesthesia is risk of inhaling saliva= choking, so this is prevented
PNS lower HR/contractility, combined with anaesthesia causes hypotension so drug prevents this
also has sedative effect eg hyoscine
use to prevent motion sickness (what is it)
this is a sensory mismatch- visual info comes into eyes, and info relating balance/posture coming through ear via labyrinth- if they are telling different things, info goes via cholinergic nerve to vomiting center= nausea
hyoscine patch is very lipid soluble, so diffuses through skin into blood stream, and blocks muscarinic receptor in vomiting centre
what is parkinsons disease
loss of dopaminergic neurones from substantia nigra to striata= loss of dopamine
D1 receptors respond to this dopamne to control fine muscle movement- lack of stimulation occurs in parkisons
use in parkisons
muscarinic receptors (M4) surpress D1 receptors in case they are overactivated- by blocking these receptors, D1receptors are more sensitive= useful for parkisons
respiratory use of muscarinic antagonists, and what drug used
asthma/COPD-prevents bronchoconstriction
ipratropium bromide used rather than atropine to prevent side effecs from systemic effects- ipratropium is charged, so not lipid soluble, so mainly effects lungs- atropine is not charged
gastrointestinal use and type of drug
used in IBS, where there is a hyperreactive gut- hence less motility/secretion
M3 antagonist
unwanted side effects of muscarinic
HOT- less sweating
DRY- less sweat, saliva and GI secretions
BLIND- cyclopegia where ability of lens to focus reduced= fuzzy
CRAZY- agitate due to CNS effect
overdose of atropine treatment
too many anti-muscarinic symptoms, so physostigmine (anti-cholinesterase) given to prevent metabolism to ACH= outcompetes ACH
effect of botulinum toxin
most toxic protein- prevents ACH going into vesicle (SNARE complex), thus prevent ACH leaving and binding to ANS/skeletal muscle
used to paralyse skeletal muscle in face to remove wrinkles, or as botox for sweating- but MUST be localised